Methamphetamine

From RACKWiki
Methamphetamine
Drug class Stimulant (Amphetamine)
Health risk High (Cardiotoxicity, neurotoxicity, risk of fatal overdose)
Addiction risk Very high (Physical and psychological dependence)
Legal status Illegal in most jurisdictions; Schedule II (USA) for prescription use (Desoxyn)

Methamphetamine (also known as crystal meth, Tina, T, or crank) is a potent central nervous system (CNS) stimulant of the amphetamine class.[1] It is commonly used in chemsex contexts, often referred to as “partying” or “PNP” (party and play). The term “crystal” refers to the translucent crystalline form typically encountered in illicit use.[2]

Background

Methamphetamine was first synthesised in 1893 and has been used medically as a second-line treatment for attention deficit hyperactivity disorder (ADHD) and, in rare cases, for exogenous obesity, under the brand name Desoxyn.[3] The illicit form is almost exclusively produced in clandestine laboratories and is associated with high abuse potential.

Medical uses

Prescription methamphetamine is approved for ADHD in children over 6 and adults when first-line treatments are ineffective, and for short-term obesity management that has not responded to other therapies.[3] Due to its high abuse liability and the availability of safer alternatives, medical use is extremely limited and tightly controlled.

Mechanism of action

Methamphetamine acts as a substrate for the vesicular monoamine transporter 2 (VMAT2) and the plasma membrane transporters for dopamine (DAT), norepinephrine (NET), and serotonin (SERT).[4] It enters presynaptic neurons and displaces monoamines from synaptic vesicles, leading to massive efflux of dopamine, norepinephrine, and serotonin into the synapse. Simultaneously, it inhibits monoamine reuptake and weakly inhibits monoamine oxidase.[5] The resulting surge in dopamine is primarily responsible for euphoria, increased energy, and heightened focus; norepinephrine release causes cardiovascular effects (tachycardia, hypertension), and serotonergic activity contributes to mood elevation.

Routes of administration

Illicit methamphetamine is used via several routes:

  • Injection (slamming): The drug is dissolved in water and injected intravenously, producing an immediate intense rush. High risk of overdose, infection (HIV, hepatitis C), and vascular damage.[1]
  • Smoking (“clouds”): The crystalline form is heated and inhaled. Onset is rapid, bioavailability is high, and this route is strongly associated with compulsive use.[1]
  • Rectal administration (booty bump, bumping): A dissolved solution or small crystal shard is inserted rectally. Absorption is rapid due to the rich vascular supply of the rectum, avoiding first-pass metabolism, but carries risk of tissue damage and unpredictable absorption.[6]
  • Insufflation (snorting) and oral ingestion are less common in chemsex settings but are sometimes used.

Appeal

In chemsex, methamphetamine is prized for its ability to induce intense euphoria, eliminate fatigue, heighten libido, and prolong sexual sessions.[7] Disinhibition and a sense of connectedness further reinforce its use in group sexual activity.

Dosing

Dosage varies widely depending on route, tolerance, and purity. The following values are approximate and based on user reports; they are not recommendations but serve as an orientation for harm reduction. All use carries risk; any dose can be dangerous.[8]

Route Threshold Light Common Strong Heavy
Oral 5 mg 5–10 mg 10–30 mg 30–50 mg 50 mg +
Insufflated 5 mg 5–15 mg 15–30 mg 30–50 mg 50 mg +
Smoked 5 mg 5–10 mg 10–20 mg 20–40 mg 40 mg +
Intravenous 5 mg 5–10 mg 10–25 mg 25–50 mg 50 mg +

Caution: Purity of street methamphetamine is highly variable; fentanyl adulteration is a life-threatening risk in many regions. Always start with a very small test dose and use drug-checking services where available.[9]

Risks

Methamphetamine is a high-potency stimulant that places severe strain on the cardiovascular system. Acute effects include tachycardia, hypertension, hyperthermia, and arrhythmias. The risk of myocardial infarction (heart attack), stroke, and aortic dissection is substantially elevated.[4][10] Neurological risks include seizures, intracerebral haemorrhage, and, at high repeated doses, persistent neurotoxicity (damage to dopamine and serotonin neurons).[11]

Psychiatric complications are common: agitation, paranoia, hallucinations, and full-blown methamphetamine-induced psychosis, which can persist for weeks or months even after cessation.[12] Severe dehydration and hyperthermia can lead to multi-organ failure.

A significant fraction of methamphetamine is excreted unchanged in urine (up to 40–50% depending on urine pH).[13] This is why drinking the urine of someone who has used methamphetamine can cause intoxication (often referred to as “chempiss”). This practice carries additional risks of infection and electrolyte imbalance.

Injecting methamphetamine with shared or non-sterile equipment significantly increases the risk of contracting blood-borne viruses such as HIV and hepatitis C, as well as bacterial endocarditis, abscesses, and vein sclerosis.[14]

The comedown (crash) typically involves severe fatigue, depression, irritability, and sleep disturbances that can last several days. Long-term use can lead to cognitive deficits, anhedonia, and structural brain changes visible on imaging.[15]

Drug interactions

  • Other stimulants (including caffeine, cocaine, MDMA): Additive cardiovascular strain, hyperthermia, and increased risk of arrhythmias.[4]
  • Monoamine oxidase inhibitors (MAOIs, e.g., some antidepressants): Can precipitate hypertensive crisis with severe hypertension, headache, and stroke. Avoid concomitant use.[16]
  • Serotonergic agents (SSRIs, SNRIs, tramadol, St. John's Wort): Increased risk of serotonin syndrome (agitation, hyperthermia, clonus, autonomic instability).[17]
  • Alcohol: Masking of intoxication, greater cardiovascular load, and increased risk of impulsive behaviour.
  • Antipsychotics and sedatives: May be used to manage acute agitation but can lead to over-sedation; careful monitoring required.

Addiction

Methamphetamine is one of the most addictive recreational substances. It produces a rapid, intense reward that leads to compulsive use and loss of control. Physical and psychological dependence develop quickly; tolerance escalates, requiring higher doses to achieve the same effect.[1] Withdrawal symptoms include profound fatigue, hypersomnia or insomnia, increased appetite, anhedonia, anxiety, and drug craving. Protracted withdrawal may persist for weeks, with cognitive deficits and anhedonia lasting months.[18] There are currently no FDA-approved pharmacological treatments for methamphetamine use disorder; behavioural therapies (e.g., the Matrix Model, contingency management) are the standard of care.[19]

Risk mitigation

Harm reduction strategies can reduce some of the acute risks, though no method eliminates harm entirely.

  • Injection safety: Use a new, sterile needle and syringe for each injection; never share equipment. Use sterile water for injection (not tap water). Clean the injection site with an alcohol swab and use a sterile filter. Use low dead-space syringes to minimise blood-borne virus transmission.[20]
  • Drug checking: Test for fentanyl and other adulterants using immunoassay strips or more advanced reagent/presumptive tests. Fentanyl contamination is a leading cause of fatal overdose in stimulant users.[9]
  • Hydration and nutrition: Monitor urine colour—pale yellow indicates adequate hydration; clear urine may indicate over-hydration (risk of hyponatremia), while dark urine suggests dehydration. Methamphetamine suppresses appetite; consume protein shakes, electrolyte drinks, and vitamin supplements to maintain energy, but avoid sudden large meals after prolonged fasting.
  • Comedown care: The crash can be psychologically distressing. A calm environment is helpful; avoid overstimulating activities (loud music, action movies). Gentle television, cartoons, or quiet social support can ease anxiety. Do not drive or operate machinery until fully recovered. If paranoid or hallucinating, a trusted, sober companion can provide reassurance and prevent dangerous behaviour.
  • Overheating: Take breaks from physical exertion, cool down with wet towels, and seek shade. Hyperthermia is a medical emergency.
  • Overdose recognition: Signs include severe chest pain, difficulty breathing, extreme agitation, loss of consciousness, seizures, and dangerously high body temperature. Call emergency services immediately. Administer basic life support; naloxone is not effective for methamphetamine overdose but may be given if co-ingestion of opioids is suspected.[21]
  • Sexual health: Methamphetamine use in chemsex is linked to condomless sex and prolonged sessions, increasing STI risk. Use condoms, pre-exposure prophylaxis (PrEP) for HIV, and have regular sexual health check-ups.
  • Seeking help: If use interferes with work, relationships, or health, contact a local drug counselling service or addiction medicine specialist. Many countries offer confidential helplines.

Known incidents

Medical case reports

Numerous case reports document severe outcomes associated with methamphetamine use, including:

  • Methamphetamine-induced cardiomyopathy requiring heart transplantation.[22]
  • Acute aortic dissection in young adults with no prior history of hypertension.[23]
  • Prolonged methamphetamine-induced psychosis misdiagnosed as schizophrenia.[24]
  • Serotonin syndrome following co-administration of methamphetamine with SSRIs.[25]

RACKWiki incident reports

Community-submitted incident reports are collected on the RACKWiki incident page. Editors are encouraged to add anonymised, verified adverse events to improve collective knowledge. Visit the Methamphetamine Incident Reports page for current submissions.

References

  1. ↑ 1.0 1.1 1.2 1.3 "Methamphetamine DrugFacts". National Institute on Drug Abuse (NIDA). Retrieved 2026-07-14.
  2. ↑ "Methamphetamine". United States Drug Enforcement Administration. Retrieved 2026-07-14.
  3. ↑ 3.0 3.1 Desoxyn (methamphetamine hydrochloride) prescribing information. AbbVie Inc. 2023. FDA label
  4. ↑ 4.0 4.1 4.2 Yasaei, R.; Saadabadi, A. (2024). "Methamphetamine". StatPearls [Internet]. StatPearls Publishing.
  5. ↑ Fleckenstein, A. E.; Volz, T. J.; Riddle, E. L.; Gibb, J. W.; Hanson, G. R. (2007). "New insights into the mechanism of action of amphetamines". Annual Review of Pharmacology and Toxicology. 47: 681–698. doi:10.1146/annurev.pharmtox.47.120505.105140.
  6. ↑ "Methamphetamine – Rectal Use". Erowid. Retrieved 2026-07-14.
  7. ↑ Giorgetti, R.; Tagliabracci, A.; Schifano, F.; Zaami, S.; Marinelli, E.; Busardò, F. P. (2017). "When "Chems" Meet Sex: A Rising Phenomenon Called "ChemSex"". Current Neuropharmacology. 15 (5): 762–770. doi:10.2174/1570159X15666161117151148.
  8. ↑ "Methamphetamine Dose". Erowid. Retrieved 2026-07-14.
  9. ↑ 9.0 9.1 "Fentanyl Facts". Centers for Disease Control and Prevention. 2024.
  10. ↑ Kaye, S.; McKetin, R.; Duflou, J.; Dark, S. (2007). "Methamphetamine and cardiovascular pathology: a review of the evidence". Addiction. 102 (8): 1204–1211. doi:10.1111/j.1360-0443.2007.01874.x.
  11. ↑ Volkow, N. D.; Morales, M. (2015). "The Brain on Drugs: From Reward to Addiction". Cell. 162 (4): 712–725. doi:10.1016/j.cell.2015.07.046.
  12. ↑ McKetin, R.; Lubman, D. I.; Baker, A. L.; Dawe, S.; Ali, R. L. (2016). "Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study". JAMA Psychiatry. 73 (4): 369–376. doi:10.1001/jamapsychiatry.2016.0019.
  13. ↑ Baselt, Randall C. (2017). Disposition of Toxic Drugs and Chemicals in Man (11th ed.). Biomedical Publications. pp. 1253–1255. ISBN 978-0-692-77499-1.
  14. ↑ "People who inject drugs". World Health Organization.
  15. ↑ Thompson, P. M.; Hayashi, K. M.; Simon, S. L.; Geaga, J. A.; Hong, M. S.; Sui, Y.; ... & London, E. D. (2004). "Structural abnormalities in the brains of human subjects who use methamphetamine". Journal of Neuroscience. 24 (26): 6028–6036. doi:10.1523/JNEUROSCI.0713-04.2004.
  16. ↑ "Methamphetamine - Drug Interactions". Drugs.com. Retrieved 2026-07-14.
  17. ↑ Boyer, E. W.; Shannon, M. (2005). "The Serotonin Syndrome". New England Journal of Medicine. 352: 1112–1120. doi:10.1056/NEJMra041867.
  18. ↑ McGregor, C.; Srisurapanont, M.; Jittiwutikarn, J.; Laobhripatr, S.; Wongtan, T.; White, J. M. (2005). "The nature, time course and severity of methamphetamine withdrawal". Addiction. 100 (9): 1320–1329. doi:10.1111/j.1360-0443.2005.01160.x.
  19. ↑ "Methamphetamine Treatment". NIDA. Retrieved 2026-07-14.
  20. ↑ "Injecting Drug Use: Best Practice Guide". International Network of People Who Use Drugs.
  21. ↑ "Stimulant Overdose". SAMHSA. Retrieved 2026-07-14.
  22. ↑ Wijetunga, M.; Seto, T.; Lindsay, J.; Schatz, I. (2003). "Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?". Journal of Toxicology. Clinical Toxicology. 41 (7): 981–986. doi:10.1081/CLT-120026521.
  23. ↑ Tsao, Y. T.; Lai, J. N.; Wang, W. J.; Hsu, Y. H.; Wu, V. C. (2018). "Methamphetamine-associated acute aortic dissection". American Journal of Emergency Medicine. 36 (11): 2118.e1–2118.e3. doi:10.1016/j.ajem.2018.05.067.
  24. ↑ Mancino, M. J.; Abdi, P.; Chowdhury, T.; Grunberg, V.; Gorelick, D. A. (2017). "Methamphetamine-Associated Psychosis". Current Psychiatry Reports. 19 (11): 80. doi:10.1007/s11920-017-0835-5.
  25. ↑ Sporer, K. A. (2003). "The Serotonin Syndrome. Implicated drugs, pathophysiology and management". Drug Safety. 26 (4): 259–268. doi:10.2165/00002018-200326040-00004.
Retrieved from "https://rackwiki.org/w/index.php?title=Methamphetamine&oldid=2159"